Lantidra Solution
Product Images NDC 73539-001

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lantidra (NDC 73539-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrans Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lantidra 01)

A horizontal bar chart comparing insulin use and insulin independence over months post first treatment for two studies. Black bars represent insulin use, white bars indicate insulin independence. The x-axis shows months post-treatment ranging from 0 to 170. Various arrow markers denote time points labeled Tx2 and Tx3. The chart tracks patient outcomes over time related to LANTIDRA (donislecel) treatment.*

FDA Label Image

Principal Display Panel (LANTIDRA Bag Label)

LANTIDRA (donislecel) packaging label for a cellular therapy solution containing allogeneic pancreatic islets for hepatic portal infusion. The label includes dosage instructions, storage conditions, and Lot, EIN, and recipient information fields. Manufactured by CellTrans Inc., Chicago, IL. The NDC is 73539-001-01.*

FDA Label Image

Principal Display Panel (RINSE Bag Label)

This label text panel provides instructions for the use of a rinse bag following hepatic portal infusion of LANTIDRA (Donislecel), an allogeneic pancreatic islets cellular therapy. It includes details on product administration timing, storage conditions, filtration instructions, rinse bag volume, and disposal guidelines. The label specifies it is for intended recipient use only and includes fields for lot number, manufacturing date, recipient identification, and biohazard disposal information. Manufacturer CellTrans Inc. contact details are also provided.*

FDA Label Image

Principal Display Panel (Secondary Container Label)

Text panel describing the contents within the overwrap of LANTIDRA, stating it includes one sterile bag for Allogeneic Islet Cell Suspension for hepatic portal infusion, attached to one sterile bag for Rinse infusion.*

FDA Label Image

Principal Display Panel (Carrier Label)

Text panel from LANTIDRA, detailing the contents of the carrier system including CryoMACS bags and associated items, accompanying documentation such as donor eligibility records and certificates, label affixation instructions for the CryoMACS bags, and transport details describing the carrier movement from CellTrans to UIHealth's Department of Radiology.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.